Primary antiphospholipid syndrome presenting as HELLP syndrome: A clinical pathology conference held by the division of rheumatology at hospital for special surgery

HSS Journal

Volumn 3, Issue 2, 2007, Pages 216-221

  George, Diane ^a   Vasanth, Lisa ^b   Erkan, Doruk ^b   Bass, Anne ^b   Salmon, Jane ^b   Lockshin, Michael D ^b  

^a ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34848919162     PISSN: 15563316     EISSN: 15563324     Source Type: Journal    
DOI: 10.1007/s11420-007-9043-6     Document Type: Article

References (27)

1. Salafia CM, Pezzulo JC, Lopez-Zeno JA, Minior VK et al (1995) Placental pathologic features of preterm pre-eclampsia. Am J Obstet Gynecol 173(4):1097-1105
2. Shanklin DR, Sibai BM (1989) Ultrastructural aspects of preeclampsia I. Placental bed and uterine boundary vessels. Am J Obstet Gynecol 161(3):735-741
3. Martin JN Jr, Rinehart BK, May WL et al (1999) The spectrum of severe preeclampsia: Comparative analysis by HELLP (hemolysis, elevated liver enzyme levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 180(6 Pt 1):1373-1384
4. Curtin WM, Weinstein L (1999) A Review of HELLP syndrome: State of the Art. J Perinatol 19(2):138-143
5. Baxter JK, Weinstein L (2004) HELLP syndrome: the state of the art. Obstet Gynecol Surv 59(12):838-845
6. Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42(7):1309-1311
7. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295-306
8. Branch DW, Silver RM, Blackwell JL, Reading JC, Scott JR (1992) Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience. Obstet Gynecol 80(4):614-620
9. Le Thi Thuong D, Tieulie N, Costedoat N et al (2005) The HELLP syndrome in the antiphospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 64(2):273-278
10. Huong DL, Wechsler B, Bletry O et al (2001) A study of 75 pregnancies in patients with the antiphospholipid syndrome. J Rheumatol 28:2025-2030
11. Branch DW, Scott JR, Kochenour NK et al (1985) Obstetric complications associated with the lupus anticoagulant. N Engl J Med 313(21):1322-1326
12. Rote NS, Walter A, Lyden TW et al (1992) Antiphospholipid antibodies-lobsters or red herrings. Am J Reprod Immunol 28(1):31-37
13. Sammaritano LR (2001) Update on the management of the pregnant patient with antiphospholipid antibody. Curr Rheumatol Rep 3(3):213-221
14. Erkan D (2002) The relation between antiphospholipid syndrome-related pregnancy morbidity and non-gravid vascular thrombosis: review of the literature and management strategies. Curr Rheumatol Rep 4(5):379-386
15. Magid MS, Kaplan C, Sammaritano LR et al (1998) Placental pathology in systemic lupus erythematosus: a prospective study. Am J Obstet Gynecol 179(1):226-234
16. Van Horn JT, Craven C, Ward K et al (2004) Histologic features of placentas and abortion specimens from women with antiphospholipid and antiphospholipid like syndromes. Placenta 25(7):642-648
17. Infante-Rievard C, David M, Gauthier R et al (1991) Lupus anticoagulants, anticardiolipin antibodies and fetal loss. N Engl J Med 325(15):1063-1066
18. Rand JH, Wu XX, Andree HA et al (1997) Pregnancy loss in the antiphospholipid-antibody syndrome-a possible thrombogenic mechanism. N Engl J Med 337(3):154-160.
19. Simantov R, LaSala J, Lo SK et al (1995) Activation of cultured vascular endothelium by antiphospholipid antibodies. J Clin Invest 96:2211-2219
20. Pierangeli SS, Colden-Stanfield M, Liu X et al (1999) Antiphospholipid antibodies from antiphospholipid syndrome patients activate endothelial cells in vitro and in vivo. Circulation 99(15):1997-2002
21. Branch DW, Dudley DJ, Mitchell MD et al (1990) Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BABL/c mice: a model for autoimmune fetal loss. Am J Obstet Gynecol 163(1 Pt 1):210-216
22. Holers VM, Girardi G, Guthridge GM et al (2002) Complement C3 activation is required for antiphospholipid antibody-induced fetal loss. J Exp Med 195(2):211-220
23. Girardi G, Redecha P, Berman J et al (2004) Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest 112(11):1644-1654
24. Pierangeli SS, Girardi G, Vega-Ostertag M et al (2005) Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia. Arthritis Rheum 52(7):2120-2124
25. Girardi G, Redecha P, Salmon JE (2004) Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation. Nat Med 10(11):1222-1226
26. Derekson RH, De Groot PG, Kater L, Nieuwenhuis HK (1993) Patients with Antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment. Ann Rheum Dis 52:689-692
27. Sibai BM (2004) Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 103(5 Pt 1):981-991